Rocket Pharmaceuticals (RCKT) Share-based Compensation (2014 - 2026)
Rocket Pharmaceuticals' Share-based Compensation came in at $7.42 million for Q2 2026, down 31.7% from $10.86 million a year earlier and down 12.6% from the prior quarter.
Powered by 
Analysis
Rocket Pharmaceuticals (RCKT) Share-based Compensation (2014 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Rocket Pharmaceuticals reported Share-based Compensation of $31.78 million, down 27.0% year-over-year; for FY2025, it was $37.06 million, down 15.6% from FY2024.
- Share-based Compensation carries a five-year compound annual growth rate of 14.8% (FY2020 to FY2025).
- Going back by year, Share-based Compensation was $43.92 million in FY2024 (+11.5%), $39.41 million in FY2023 (+27.1%), $31.01 million in FY2022 (+6.1%) and $29.24 million in FY2021 (+57.5%).
- The five-year range for quarterly Share-based Compensation is $6.11 million (Q4 2025) to $11.33 million (Q2 2024).
- Year-over-year, Share-based Compensation has declined for five consecutive quarters, with an average decline of 11.3% over the last eight quarters.
- The fastest year-over-year change in Share-based Compensation over five years came in Q3 2021 (growth of 72.7%), and the weakest in Q4 2025 (a decline of 44.9%).
- Business Quant data shows RCKT's Share-based Compensation at $8.49 million (Q1 2026), $6.11 million (Q4 2025) and $9.76 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | - |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Rocket Pharmaceuticals | 283.71 Mn | 283.71 Mn | - | 7.42 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.42 Mn |
| Mar 31, 2026 | 8.49 Mn |
| Dec 31, 2025 | 6.11 Mn |
| Sep 30, 2025 | 9.76 Mn |
| Jun 30, 2025 | 10.86 Mn |
| Mar 31, 2025 | 10.33 Mn |
| Dec 31, 2024 | 11.09 Mn |
| Sep 30, 2024 | 11.25 Mn |
| Jun 30, 2024 | 11.33 Mn |
| Mar 31, 2024 | 10.25 Mn |
| Dec 31, 2023 | 9.93 Mn |
| Sep 30, 2023 | 10.32 Mn |
| Jun 30, 2023 | 10.25 Mn |
| Mar 31, 2023 | 8.92 Mn |
| Dec 31, 2022 | 9.69 Mn |
| Sep 30, 2022 | 7.68 Mn |
| Jun 30, 2022 | 7.37 Mn |
| Mar 31, 2022 | 6.27 Mn |
| Dec 31, 2021 | 7.04 Mn |
| Sep 30, 2021 | 6.99 Mn |
API Access
Rocket Pharmaceuticals Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=RCKT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "RCKT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=RCKT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();